Main
>
ONCOLOGY (**)
>
Leukemia>Lymphocytic>Chronic ***
>
Treatment
>
USA. A. Ibrutinib ***
>
(*) USA Approval Date: 2016. 03.04>
First Line Treat.
(*) USA Approval Date: 2016. 03.04>'s products
This section has no products